S. 2760 · Where this bill is now
In committee
Introduced in the Senate, Sep 10, 2025
What this bill does
In plain words · AI-written from the official summaryMedicare covers hereditary cancer testing and prevention
This bill expands Medicare coverage to include genetic testing for people who have a personal or family history of hereditary cancer. If the testing is done, Medicare would also cover certain risk-reducing surgeries and preventive screenings for those who need them.
How it affects you
If you're on Medicare and have a family history of hereditary cancer, this could mean you'd get coverage for genetic testing to see if you carry a mutation that increases cancer risk. If testing shows you do carry a hereditary cancer gene, you could get Medicare coverage for surgeries or screenings meant to reduce that risk.
Read the official summary (Introduced in Senate, Sep 10, 2025)
Reducing Hereditary Cancer Act of 2025
This bill provides for Medicare coverage of germline mutation testing for individuals with a personal or family history of a hereditary cancer gene mutation or suspected history of hereditary cancer, as well as for associated coverage of risk-reducing surgeries and screenings.
Written by AI (Claude) using only the official summary by the Congressional Research Service, the Library of Congress’s nonpartisan research staff. It can miss nuance, so check the official summary and the bill text for details.
1st SessionS. 2760
A BILL
Reducing Hereditary Cancer Act of 2025
Sponsor: Sen. Lisa Murkowski (R-AK) · Introduced Sep 10, 2025 · Health · 1 version of the text
Sources: Congress.gov actions and votes · bill text from GovInfo · latest official action Sep 10, 2025: “Read twice and referred to the Committee on Finance.”
Sections
Sections · 4
- Sec. 1Short titleNo change
- Sec. 2Hereditary cancer genetic testing of individuals with a family history of a hereditary cancer gene mutation or personal or family history suspicious for hereditary cancerNo change
- Sec. 3Coverage of certain preventive surgeriesNo change
- Sec. 4Coverage of evidence-based screenings for individuals with a hereditary cancer gene mutationNo change